Ignite Creation Date:
2025-12-25 @ 5:05 AM
Ignite Modification Date:
2025-12-26 @ 4:08 AM
Study NCT ID:
NCT00044018
Status:
COMPLETED
Last Update Posted:
2019-11-12
First Post:
2002-08-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2004-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-02-15
Completion Date Type:
ACTUAL
First Submit Date:
2002-08-16
First Submit QC Date:
None
Study First Post Date:
2002-08-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL